Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: A meta-analysis of randomized controlled trials

JACC: Cardiovascular Interventions

Volumn 7, Issue 5, 2014, Pages 497-506

  Al Ali, Juwairia ^a   Franck, Caroline ^b   Filion, Kristian B ^b,c   Eisenberg, Mark J ^b,c,d  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

coronary artery bypass graft; drug eluting stent(s); meta analysis

Indexed keywords

ARTICLE; BARE METAL STENT; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; LEFT ANTERIOR DESCENDING CORONARY ARTERY; META ANALYSIS; MORTALITY; PACLITAXEL ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIROLIMUS ELUTING STENT; SYSTEMATIC REVIEW; ADVERSE EFFECTS; DEVICES; MYOCARDIAL INFARCTION; PATIENT SELECTION; PROSTHESIS; RISK; RISK ASSESSMENT; RISK FACTOR; STROKE; TREATMENT OUTCOME; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; LEFT CORONARY ARTERY; PATIENT SAFETY; REVASCULARIZATION;

CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 84901354515     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.12.202     Document Type: Review

References (27)

1. Y. Luo, X. Yu, and F. Chen et al. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting Coron Artery Dis 23 2012 322 329
2. S.W. Lee, S.H. Kim, and S.O. Kim et al. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry Catheter Cardiovasc Interv 80 2012 206 212
3. D. Kawecki, B. Morawiec, M. Fudal, W. Milejski, W. Jacheć, and E. Nowalany-Kozielska Comparison of coronary artery bypass grafting with percutaneous coronary intervention for unprotected left main coronary artery disease Yonsei Med J 53 2012 58 67
4. S.J. Head, A. Bogers, and A.P. Kappetein Drug-eluting stent implantation for coronary artery disease: current stents and a comparison with bypass surgery Curr Opin Pharmacol 12 2012 147 154
5. K. Ahmed, M.H. Jeong, R. Chakraborty for the Korea Acute Myocardial Infarction Registry Investigators Percutaneous coronary intervention with drug-eluting stent implantation vs. coronary artery bypass grafting for multivessel coronary artery disease in metabolic syndrome patients with acute myocardial infarction Circ J 76 2012 721 728
6. A. Liberati, D.G. Altman, and J. Tetzlaff et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
7. J. Higgins, S. Green Cochrane Collaboration Cochrane Handbook for Systematic Reviews of Interventions 2008 John Wiley & Sons Hoboken, NJ
8. A. Kapur, R.J. Hall, and I.S. Malik et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients: 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial J Am Coll Cardiol 55 2010 432 440
9. P.W. Serruys, M.C. Morice, A.P. Kappetein for the SYNTAX Investigators Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
10. M.E. Farkouh, M. Domanski, L.A. Sleeper for the FREEDOM Trial Investigators Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
11. F. Mohr, S. Redwood, and G. Venn et al. Final five-year follow-up of the SYNTAX trial: optimal revascularization strategy in patients with three-vessel disease (abstr) J Am Coll Cardiol 60 2012 B13
12. E. Boudriot, H. Thiele, and T. Walther et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis J Am Coll Cardiol 57 2011 538 545
13. S.J. Park, Y.H. Kim, and D.W. Park et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease N Engl J Med 364 2011 1718 1727
14. P. Serruys, G. Religa, and W. Ruzyllo et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for left main disease: final five-year follow-up of the SYNTAX trial (abstr) J Am Coll Cardiol 60 2012 B13
15. H. Thiele, P. Neumann-Schniedewind, and S. Jacobs et al. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis J Am Coll Cardiol 53 2009 2324 2331
16. S.J. Hong, D.S. Lim, and H.S. Seo et al. Percutaneous coronary intervention with drug-eluting stent implantation vs. minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis Catheter Cardiovasc Interv 64 2005 75 81
17. S.G. Ellis Coronary revascularization for patients with diabetes: updated data favor coronary artery bypass grafting J Am Coll Cardiol 61 2013 817 819
18. A.P. Kappetein, S.J. Head, M.C. Morice for the SYNTAX Investigators Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial Eur J Cardiothorac Surg 43 2013 1006 1013
19. P.W. Serruys, Y. Onuma, S. Garg for the ARTS II Investigators 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions J Am Coll Cardiol 55 2010 1093 1101
20. M. Alam, H.D. Huang, and S.A. Shahzad et al. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era - an aggregate data meta-analysis of 11,148 patients Circ J 77 2013 372 382
21. F.W. Mohr, M.C. Morice, and A.P. Kappetein et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial Lancet 381 2013 629 638
22. A. Chieffo, E. Meliga, and A. Latib et al. Drug-eluting stent for left main coronary artery disease: the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment J Am Coll Cardiol Intv 5 2012 718 727
23. J.S. Jang, K.N. Choi, and H.Y. Jin et al. Meta-analysis of three randomized trials and nine observational studies comparing drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary artery disease Am J Cardiol 110 2012 1411 1418
24. H. Thiele, S. Oettel, and S. Jacobs et al. Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: a 5-year follow-up Circulation 112 2005 3445 3450
25. V. Farooq, D. van Klaveren, and E.W. Steyerberg et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381 2013 639 650
26. G.W. Stone, A. Rizvi, and W. Newman et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
27. S.H. Hofma, J. Brouwer, and M.A. Velders et al. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial J Am Coll Cardiol 60 2012 381 387